Arch Therapeutics
Focus: Arch Therapeutics is a medical device company focused on surgical hemostats and fluid leakage prevention, headquartered in Framingham, MA. The company operates at an early stage with a small active job market (6 open roles) and limited disclosed scale.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
6
Should You Work at Arch Therapeutics?
AI assessmentA high-risk, high-autonomy early-stage device play best suited for specialists willing to bet on unproven commercial execution in exchange for equity upside and operational influence.
Why Work Here
- Early-stage device innovator with focused pipeline in high-need surgical and wound-care markets (oncology, diabetic foot ulcers)
- Small, lean team structure (6 active roles) offers high visibility and direct impact on product development decisions
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
N/A
Clinical Trials (2)
NCT02704104Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin Lesions
N/AHelp build intelligence for Arch Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.